Review Article | Published:

The clinical importance of emerging Campylobacter species

Nature Reviews Gastroenterology & Hepatology volume 8, pages 669685 (2011) | Download Citation

Abstract

A growing number of Campylobacter species other than C. jejuni and C. coli have been recognized as emerging human and animal pathogens. Although C. jejuni continues to be the leading cause of bacterial gastroenteritis in humans worldwide, advances in molecular biology and development of innovative culture methodologies have led to the detection and isolation of a range of under-recognized and nutritionally fastidious Campylobacter spp., including C. concisus, C. upsaliensis and C. ureolyticus. These emerging Campylobacter spp. have been associated with a range of gastrointestinal diseases, particularly gastroenteritis, IBD and periodontitis. In some instances, infection of the gastrointestinal tract by these bacteria can progress to life-threatening extragastrointestinal diseases. Studies have shown that several emerging Campylobacter spp. have the ability to attach to and invade human intestinal epithelial cells and macrophages, damage intestinal barrier integrity, secrete toxins and strategically evade host immune responses. Members of the Campylobacter genus naturally colonize a wide range of hosts (including pets, farm animals and wild animals) and are frequently found in contaminated food products, which indicates that these bacteria are at risk of zoonotic transmission to humans. This Review presents the latest information on the role and clinical importance of emerging Campylobacter spp. in gastrointestinal health and disease.

Key points

  • Members of the Campylobacter genus are ecologically diverse and readily colonize humans and animals

  • C. jejuni and C. coli are established pathogens in human gastroenteritis, but other Campylobacter species (the 'emerging' pathogens) also have a role in gastrointestinal and extragastrointestinal infections in humans

  • The pathogenic mechanisms used by emerging Campylobacter spp. are diverse, and include attachment and invasion, production of toxins that modulate host functions and evasion of host defense systems

  • Emerging Campylobacter spp. pose a substantial risk of zoonotic transmission as these species colonize pets, farm animals and wild animals, and can be found in contaminated food products

  • Ongoing epidemiological surveillance of emerging Campylobacter spp. is key to understanding the distribution and zoonosis of these potentially novel and emerging pathogens

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , & The serotype and biotype distribution of clinical isolates of Campylobacter jejuni and Campylobacter coli over a three-year period. J. Infect. Dis. 147, 243–246 (1983).

  2. 2.

    , , & The importance of Campylobacter coli in human campylobacteriosis: prevalence and genetic characterization. Epidemiol. Infect. 133, 1081–1087 (2005).

  3. 3.

    et al. Prevalence of putative virulence markers in Campylobacter jejuni and Campylobacter coli isolated from hospitalized children, raw chicken, and raw beef in Tehran, Iran. Can. J. Microbiol. 57, 143–148 (2011).

  4. 4.

    et al. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites. Clin. Infect. Dis. 38 (Suppl. 3), S285–S296 (2004).

  5. 5.

    et al. Campylobacter. Vet. Res. 36, 351–382 (2005).

  6. 6.

    , & Campylobacter upsaliensis: waiting in the wings. Clin. Microbiol. Rev. 11, 440–449 (1998).

  7. 7.

    Emerging Campylobacter spp.: the tip of the iceberg. Clin. Microbiol. Newsletter 28, 49–56 (2006).

  8. 8.

    & in Campylobacter, 2nd edn (eds. Nachamkin, I. & Blaser, M. J.) 89–120 (American Society for Microbiology, Washington, 2000).

  9. 9.

    A gastro-enteritis cutbreak probably due to a bovine strain of Vibrio. Yale J. Biol. Med. 18, 243–258 (1946).

  10. 10.

    Human infections with Vibrio fetus and a closely related vibrio. J. Infect. Dis. 101, 119–128 (1957).

  11. 11.

    et al. Foodborne illness acquired in the United States—major pathogens. Emerg. Infect. Dis. 17, 7–15 (2011).

  12. 12.

    et al. Continued decline in the incidence of Campylobacter infections, FoodNet 1996–2006. Foodborne Pathog. Dis. 5, 329–337 (2008).

  13. 13.

    , , , & Disease risks from foods, England and Wales, 1996–2000. Emerg. Infect. Dis. 11, 365–372 (2005).

  14. 14.

    , & Age patterns of persons with campylobacteriosis, England and Wales, 1990–2007. Emerg. Infect. Dis. 15, 2046–2048 (2009).

  15. 15.

    et al. Estimating foodborne gastroenteritis, Australia. Emerg. Infect. Dis. 11, 1257–1264 (2005).

  16. 16.

    & Efficient isolation of Campylobacteria from stools. J. Clin. Microbiol. 38, 2798–2799 (2000).

  17. 17.

    et al. Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium. J. Antimicrob. Chemother. 57, 908–913 (2006).

  18. 18.

    , , & Campylobacter upsaliensis, C. sputorum sputorum and C. concisus as common causes of diarrhoea in Swedish children. Scand. J. Infect. Dis. 27, 187–188 (1995).

  19. 19.

    et al. Campylobacter upsaliensis: Another pathogen for consideration in the United States. Clin. Infect. Dis. 34, E59–E60 (2002).

  20. 20.

    et al. Clinical characteristics and serotype distribution of Campylobacter jejuni and Campylobacter coli isolated from diarrhoeic patients in Dhaka, Bangladesh, and Cape Town, South Africa. Bangladesh J. Microbiol. 23, 121–124 (2006).

  21. 21.

    , , & Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J. Clin. Microbiol. 38, 286–291 (2000).

  22. 22.

    , & 16S rRNA gene sequences of 'Candidatus Campylobacter hominis', a novel uncultivated species, are found in the gastrointestinal tract of healthy humans. Microbiology 144, 2063–2071 (1998).

  23. 23.

    et al. Isolation of Campylobacter concisus from feces of children with and without diarrhea. J. Clin. Microbiol. 34, 2304–2306 (1996).

  24. 24.

    , , & The use of (GTG)5 oligonucleotide as an RAPD primer to type Campylobacter concisus. Lett. Appl. Microbiol. 42, 600–605 (2006).

  25. 25.

    , , , & Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data. J. Clin. Microbiol. 43, 5091–5096 (2005).

  26. 26.

    et al. Campylobacter concisus: an evaluation of certain phenotypic and genotypic characteristics. Clin. Microbiol. Infect. 11, 288–295 (2005).

  27. 27.

    , & Characterization and subgrouping of Campylobacter concisus strains using protein profiles, conventional biochemical testing and antibiotic susceptibility. Eur. J. Gastroenterol. Hepatol. 17, 1019–1024 (2005).

  28. 28.

    & Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-diarrheic humans. BMC Microbiol. 11, 53 (2011).

  29. 29.

    , & Thermotolerant Campylobacter with no or weak catalase activity isolated from dogs. Curr. Microbiol. 8, 209–213 (1983).

  30. 30.

    , & DNA relatedness and biochemical features of Campylobacter spp. isolated in central and South Australia. J. Clin. Microbiol. 22, 71–74 (1985).

  31. 31.

    , , , & Isolation of group 2 aerotolerant Campylobacter species from Thai children with diarrhea. J. Infect. Dis. 163, 1062–1067 (1991).

  32. 32.

    et al. Is “Campylobacter upsaliensis” an unrecognised cause of human diarrhoea? Lancet 335, 584–586 (1990).

  33. 33.

    et al. Investigation of an outbreak of Campylobacter upsaliensis in day care centers in Brussels: analysis of relationships among isolates by phenotypic and genotypic typing methods. J. Infect. Dis. 172, 1298–1305 (1995).

  34. 34.

    & Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 27, 816–821 (1998).

  35. 35.

    & Direct isolation of atypical thermophilic Campylobacter species from human feces on selective agar medium. J. Clin. Microbiol. 27, 668–670 (1989).

  36. 36.

    , , & Water-borne outbreak of Campylobacter laridis-associated gastroenteritis. Lancet 1, 164–165 (1987).

  37. 37.

    et al. Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J. Clin. Microbiol. 21, 222–225 (1985).

  38. 38.

    et al. Campylobacter ureolyticus: an emerging gastrointestinal pathogen? FEMS Immunol. Med. Microbiol. 61, 228–230 (2011).

  39. 39.

    , , & Detection of Campylobacter in gastroenteritis: comparison of direct PCR assay of faecal samples with selective culture. Epidemiol. Infect. 121, 547–553 (1998).

  40. 40.

    , , , & Molecular-based detection of non-culturable and emerging campylobacteria in patients presenting with gastroenteritis. Epidemiol. Infect. 18, 1–5 (2011).

  41. 41.

    , & Enteric campylobacteria and RNA viruses associated with healthy and diarrheic humans in the Chinook Heath Region of Southwestern Alberta, Canada. J. Clin. Microbiol. 49, 209–219 (2011).

  42. 42.

    , & Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Quebec, Canada, from 1983 to 2000. J. Clin. Microbiol. 41, 463–466 (2003).

  43. 43.

    , & The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat. Rev. Gastroenterol. Hepatol. 8, 152–168 (2011).

  44. 44.

    & Campylobacter jejuni causing flare-up in inflammatory bowel disease. Lancet 2, 919 (1980).

  45. 45.

    et al. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J. Clin. Microbiol. 47, 453–455 (2009).

  46. 46.

    et al. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm. Bowel Dis. 16, 1008–1016 (2010).

  47. 47.

    Clinical relevance of Campylobacter concisus isolated from pediatric patients. J. Clin. Microbiol. 47, 2360 (2009).

  48. 48.

    et al. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS ONE 6, e21490 (2011).

  49. 49.

    et al. Sequencing and validation of the genome of a Campylobacter concisus reveals intra-species diversity. PLoS ONE 6, e22170 (2011).

  50. 50.

    et al. Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen. FEMS Immunol. Med. Microbiol. .

  51. 51.

    & Campylobacter species in health, gingivitis, and periodontitis. J. Dent. Res. 79, 785–792 (2000).

  52. 52.

    , , & Profiling of subgingival plaque biofilm microflora from periodontally healthy subjects and from subjects with periodontitis using quantitative real-time PCR. J. Periodontal Res. 45, 389–395 (2010).

  53. 53.

    , , , & Salivary levels of suspected periodontal pathogens in relation to periodontal status and treatment. J. Dent. Res. 74, 1789–1795 (1995).

  54. 54.

    , , & Clustering of subgingival microbial species in adolescents with periodontitis. Eur. J. Oral Sci. 119, 141–150 (2011).

  55. 55.

    et al. The distribution of periodontopathic bacteria among Japanese children and their parents. J. Periodontal Res. 39, 398–404 (2004).

  56. 56.

    et al. Detection of specific periodontal microorganisms from bacteraemia samples after periodontal therapy using molecular-based diagnostics. J. Clin. Periodontol 38, 418–427 (2011).

  57. 57.

    et al. Characterization of the invasive and inflammatory traits of oral Campylobacter rectus in a murine model of fetoplacental growth restriction and in trophoblast cultures. J. Reprod. Immunol. 84, 145–153 (2010).

  58. 58.

    , & Use of defined mutants to assess the role of the Campylobacter rectus S-layer in bacterium-epithelial cell interactions. Infect. Immun. 68, 1465–1473 (2000).

  59. 59.

    et al. Effect of Campylobacter rectus LPS on plasminogen activator-plasmin system in human gingival fibroblast cells. J. Periodontal Res. 30, 132–140 (1995).

  60. 60.

    et al. Bacteria of dental caries in primary and permanent teeth in children and young adults. J. Clin. Microbiol. 46, 1407–1417 (2008).

  61. 61.

    et al. Campylobacter insulaenigrae causing septicaemia and enteritis. J. Med. Microbiol. 56, 1565–1567 (2007).

  62. 62.

    et al. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin. Infect. Dis. 25, 1414–1420 (1997).

  63. 63.

    , , , & Campylobacter fetus-associated epidural abscess and bacteremia. J. Clin. Microbiol. 47, 857–858 (2009).

  64. 64.

    et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin. Infect. Dis. 47, 790–796 (2008).

  65. 65.

    et al. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin. Microbiol. Infect. 16, 57–61 (2010).

  66. 66.

    et al. In vitro susceptibility of “Campylobacter upsaliensis” to twenty-four antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 9, 822–824 (1990).

  67. 67.

    et al. Recurrent septicemia due to Campylobacter fetus and Campylobacter lari in an immunocompetent patient. Infection 30, 171–174 (2002).

  68. 68.

    , , & The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q. J. Med. 49, 431–442 (1980).

  69. 69.

    , & Campylobacter species isolated from extra-oro-intestinal abscesses: a report of four cases and literature review. Eur. J. Clin. Microbiol. Infect. Dis. 27, 1119–1123 (2008).

  70. 70.

    , , & Ciprofloxacin-resistant campylobacteriosis in the UK. Lancet 376, 1987 (2010).

  71. 71.

    et al. Antimicrobial resistance of Campylobacter isolates from retail meat in the United States between 2002 and 2007. Appl. Environ. Microbiol. 76, 7949–7956 (2010).

  72. 72.

    , , , & Adherence to and invasion of human intestinal epithelial cells by Campylobacter jejuni and Campylobacter coli isolates from retail meat products. J. Food Prot. 69, 768–774 (2006).

  73. 73.

    , , , & Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-κB. Infect. Immun. 76, 4498–4508 (2008).

  74. 74.

    , & Adherence, invasion, toxigenic, and chemotactic properties of Mexican Campylobacter strains. J. Food Prot. 73, 2093–2098 (2010).

  75. 75.

    et al. A genomic island defines subspecies-specific virulence features of the host-adapted pathogen Campylobacter fetus subsp. venerealis. J. Bacteriol. 192, 502–517 (2010).

  76. 76.

    et al. Invasion of human epithelial cells by Campylobacter upsaliensis. Cell. Microbiol. 5, 835–847 (2003).

  77. 77.

    et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J. Infect. Dis. 202, 1855–1865 (2010).

  78. 78.

    , & Fibronectin enhances Campylobacter fetus interaction with extracellular matrix components and INT 407 cells. Can. J. Microbiol. 54, 37–47 (2008).

  79. 79.

    Campylobacter fetus adheres to and enters INT 407 cells. Can. J. Microbiol. 48, 995–1007 (2002).

  80. 80.

    et al. Major structural differences and novel potential virulence mechanisms from the genomes of multiple Campylobacter species. PLoS Biol. 3, e15 (2005).

  81. 81.

    , , , & Adherence to lipids and intestinal mucin by a recently recognized human pathogen, Campylobacter upsaliensis. Infect. Immun. 64, 4060–4066 (1996).

  82. 82.

    et al. Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells. PLoS ONE 6, e23858 (2011).

  83. 83.

    et al. The secretome of Campylobacter concisus. FEBS J. 277, 1606–1617 (2010).

  84. 84.

    & Campylobacter fetus translocation across Caco-2 cell monolayers. Microb. Pathog. 49, 260–272 (2010).

  85. 85.

    & Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog. 4, e14 (2008).

  86. 86.

    , & In vivo virulence properties of bacterial cytolethal-distending toxin. Cell. Microbiol. 10, 1599–1607 (2008).

  87. 87.

    et al. Development of a cytolethal distending toxin (cdt) gene-based species-specific multiplex PCR assay for the detection and identification of Campylobacter jejuni, Campylobacter coli and Campylobacter fetus. FEMS Immunol. Med. Microbiol. 52, 260–266 (2008).

  88. 88.

    , , , & Molecular and comparative analyses of the full-length cytolethal distending toxin (cdt) gene operon and its adjacent genetic loci from urease-positive thermophilic Campylobacter (UPTC) organisms. Br. J. Biomed. Sci. 67, 208–215 (2010).

  89. 89.

    et al. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect. Immun. 64, 2070–2078 (1996).

  90. 90.

    et al. Comparative analysis of cytolethal distending toxin (cdt) genes among Campylobacter jejuni, C. coli and C. fetus strains. Microb. Pathog. 42, 174–183 (2007).

  91. 91.

    & A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb. Pathog. 4, 115–126 (1988).

  92. 92.

    et al. Prevalence of cytolethal distending toxin (cdt) genes and CDT production in Campylobacter spp. isolated from Danish broilers. J. Med. Microbiol. 50, 1087–1094 (2001).

  93. 93.

    , & Production of cytolethal distending toxin (CLDT) by Campylobacter fetus subsp. fetus isolated from calves. J. Vet. Med. Sci. 55, 507–509 (1993).

  94. 94.

    et al. Campylobacter upsaliensis exerts a cytolethal distending toxin effect on HeLa cells and T lymphocytes. Microbiology 147, 735–743 (2001).

  95. 95.

    , , & Isolation and partial characterization of the Campylobacter rectus cytotoxin. Microb. Pathog. 14, 203–215 (1993).

  96. 96.

    , & Study of haemolytic activity of some Campylobacter spp. on blood agar plates. J. Appl. Bacteriol. 69, 384–389 (1990).

  97. 97.

    , , , & Characterization of a haemolytic phospholipase A(2) activity in clinical isolates of Campylobacter concisus. J. Med. Microbiol. 53, 483–493 (2004).

  98. 98.

    , , & Characterization of Campylobacter concisus hemolysins. FEMS Immunol. Med. Microbiol. 54, 224–235 (2008).

  99. 99.

    & Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. J. Clin. Microbiol. 24, 275–281 (1986).

  100. 100.

    et al. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J. Clin. Invest. 96, 710–720 (1995).

  101. 101.

    & The versatile bacterial type IV secretion systems. Nat. Rev. Microbiol. 1, 137–149 (2003).

  102. 102.

    et al. DNA sequence and mutational analyses of the pVir plasmid of Campylobacter jejuni 81–176. Infect. Immun. 70, 6242–6250 (2002).

  103. 103.

    et al. Genomic analysis of Campylobacter fetus subspecies: identification of candidate virulence determinants and diagnostic assay targets. BMC Microbiol. 9, 86 (2009).

  104. 104.

    , , , & Nucleotide sequences and comparison of two large conjugative plasmids from different Campylobacter species. Microbiology 150, 3507–3517 (2004).

  105. 105.

    & Type VI secretion: not just for pathogenesis anymore. Cell Host Microbe 8, 2–6 (2010).

  106. 106.

    & A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 7, 265–276 (2010).

  107. 107.

    US National Library of Medicine. The National Center for Biotechnology Information , (2011).

  108. 108.

    et al. Pathogenesis of Campylobacter fetus infections: serum resistance associated with high-molecular-weight surface proteins. J. Infect. Dis. 155, 696–706 (1987).

  109. 109.

    , , & Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. J. Clin. Invest. 81, 1434–1444 (1988).

  110. 110.

    et al. Role for the S-layer of Campylobacter rectus ATCC33238 in complement mediated killing and phagocytic killing by leukocytes from guinea pig and human peripheral blood. Oral Dis. 3, 113–120 (1997).

  111. 111.

    et al. Characterization and description of “Campylobacter upsaliensis” isolated from human feces. J. Clin. Microbiol. 28, 1039–1046 (1990).

  112. 112.

    & Pathogenesis of Campylobacter fetus infections: critical role of high-molecular-weight S-layer proteins in virulence. J. Infect. Dis. 167, 372–377 (1993).

  113. 113.

    , & Mechanisms underlying Campylobacter fetus pathogenesis in humans: surface-layer protein variation in relapsing infections. J. Infect. Dis. 191, 2082–2089 (2005).

  114. 114.

    & The biofilm matrix. Nat. Rev. Microbiol. 8, 623–633 (2010).

  115. 115.

    et al. Campylobacter jejuni 81–176 forms distinct microcolonies on in vitro-infected human small intestinal tissue prior to biofilm formation. Microbiology 156, 3079–3084 (2010).

  116. 116.

    & The biofilm forming potential of bacterial species in the genus Campylobacter. Food Microbiol. 26, 44–51 (2009).

  117. 117.

    et al. Extended survival and persistence of Campylobacter spp. in water and aquatic biofilms and their detection by immunofluorescent-antibody and -rRNA staining. Appl. Environ. Microbiol. 64, 733–741 (1998).

  118. 118.

    , , , & An immunohistochemical study on the localization of Porphyromonas gingivalis, Campylobacter rectus and Actinomyces viscosus in human periodontal pockets. J. Periodontal Res. 32, 598–607 (1997).

  119. 119.

    Sticky, a novel phenotype of Campylobacter rectus. Microb. Ecol. Health Dis. 8, 175–179 (1995).

  120. 120.

    , , & Pulsed-field gel electrophoresis for epidemiologic studies of Campylobacter hyointestinalis isolates. J. Clin. Microbiol. 30, 1982–1984 (1992).

  121. 121.

    , & Prevalence of Campylobacter spp. in raw retail poultry on sale in Northern Ireland. J. Food Prot. 72, 1830–1835 (2009).

  122. 122.

    , , , & The incidence of Campylobacter spp. on processed turkey from processing plants in the midwestern United States. J. Appl. Microbiol. 95, 234–241 (2003).

  123. 123.

    , , , & Risk factors for sporadic Campylobacter infections: results of a case-control study in Southeastern Norway. J. Clin. Microbiol. 30, 3117–3121 (1992).

  124. 124.

    , , & A case-control study of risk factors for sporadic Campylobacter infections in Denmark. Epidemiol. Infect. 130, 353–366 (2003).

  125. 125.

    et al. Molecular cloning, nucleotide sequencing and characterization of the flagellin gene from isolates of urease-positive thermophilic Campylobacter. Res. Microbiol. 155, 185–191 (2004).

  126. 126.

    , , & Prolonged survival of Campylobacter species in bovine manure compost. Appl. Environ. Microbiol. 76, 1110–1119 (2010).

  127. 127.

    , , & Occurrence of fastidious Campylobacter spp. in fresh meat and poultry using an adapted cultural protocol. Int. J. Food Microbiol. 150, 171–177 (2011).

  128. 128.

    , & Prevalence and antibiotic susceptibility of thermophilic Campylobacter species on beef, mutton, and chicken carcasses in Istanbul, Turkey. Microb. Drug Resist. 15, 143–149 (2009).

  129. 129.

    et al. Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin. Infect. Dis. 27, 252–255 (1998).

  130. 130.

    , & Detection and quantification of 14 Campylobacter species in pet dogs reveals an increase in species richness in feces of diarrheic animals. BMC Microbiol. 10, 73 (2010).

  131. 131.

    et al. Prevalence and shedding patterns of Campylobacter spp. in longitudinal studies of kennelled dogs. Vet. J. .

  132. 132.

    et al. Prevalence of Campylobacter spp. in a cross-sectional study of dogs attending veterinary practices in the UK and risk indicators associated with shedding. Vet. J. 184, 66–70 (2010).

  133. 133.

    Campylobacter spp isolated from dog faeces. Lancet 338, 1403 (1991).

  134. 134.

    et al. Campylobacter upsaliensis enteritis associated with canine infections. Lancet 337, 1486–1487 (1991).

  135. 135.

    & Abortion associated with Campylobacter upsaliensis. J. Clin. Microbiol. 32, 3093–3094 (1994).

  136. 136.

    et al. Campylobacter spp. in Irish feedlot cattle: a longitudinal study involving pre-harvest and harvest phases of the food chain. J. Vet. Med. B Infect. Dis. Vet. Public Health 51, 28–33 (2004).

  137. 137.

    et al. Molecular characterization of Campylobacter lanienae strains isolated from food-producing animals. Foodborne Pathog Dis. 8, 615–621 (2011).

  138. 138.

    et al. Factors associated with increased and decreased risk of Campylobacter infection: a prospective case-control study in Norway. Am. J. Epidemiol. 158, 234–242 (2003).

  139. 139.

    et al. Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. J. Infect. Dis. 197, 1477–1484 (2008).

  140. 140.

    et al. Association between potential zoonotic enteric infections in children and environmental risk factors in Quebec, 1999–2006. Zoonoses Public Health 57, e195–e205 (2010).

  141. 141.

    , , & Transmission of Campylobacter hyointestinalis from a pig to a human. J. Clin. Microbiol. 40, 2601–2605 (2002).

  142. 142.

    et al. A comparison of different culture methods for the recovery of Campylobacter species from pets. Zoonoses Public Health 56, 490–495 (2009).

  143. 143.

    , & Reassessment of selective agars and filtration techniques for isolation of Campylobacter species from faeces. Eur. J. Clin. Microbiol. Infect. Dis. 7, 155–160 (1988).

  144. 144.

    , , & Novel Campylobacter lari-like bacteria from humans and molluscs: description of Campylobacter peloridis sp. nov., Campylobacter lari subsp. concheus subsp. nov. and Campylobacter lari subsp. lari subsp. nov. Int. J. Syst. Evol. Microbiol. 59, 1126–1132 (2009).

  145. 145.

    et al. Campylobacter troglodytis - sp. nov., isolated from feces of human-habituated wild chimpanzees (Pan troglodytes schweinfurthii) in Tanzania. Appl. Environ. Microbiol. 77, 2366–2373 (2011).

  146. 146.

    , , , & Campylobacter cuniculorum sp. nov., from rabbits. Int. J. Syst. Evol. Microbiol. 59, 1666–1671 (2009).

  147. 147.

    et al. Campylobacter avium sp. nov., a hippurate-positive species isolated from poultry. Int. J. Syst. Evol. Microbiol. 59, 2364–2369 (2009).

  148. 148.

    et al. Campylobacter subantarcticus sp. nov., isolated from birds in the sub-Antarctic region. Int. J. Syst. Evol. Microbiol. 60, 815–819 (2010).

  149. 149.

    et al. Campylobacter volucris sp. nov., isolated from black-headed gulls (Larus ridibundus). Int. J. Syst. Evol. Microbiol. 60, 1870–1875 (2010).

  150. 150.

    et al. Helicobacter marmotae, novel Helicobacter sp. and Campylobacter sp. isolated from livers and intestines of Prairie dogs. J. Med. Microbiol. 60, 1366–1374 (2011).

  151. 151.

    et al. Novel gastric helicobacters and oral campylobacters are present in captive and wild cetaceans. Vet. Microbiol. 152, 138–145 (2011).

  152. 152.

    et al. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J. Infect. Dis. 153, 552–559 (1986).

  153. 153.

    , , & A PCR-DGGE method for detection and identification of Campylobacter, Helicobacter, Arcobacter and related Epsilobacteria and its application to saliva samples from humans and domestic pets. J. Appl. Microbiol. 103, 2601–2615 (2007).

  154. 154.

    , , & Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J. Clin. Microbiol. 43, 3944–55 (2005).

  155. 155.

    et al. Campylobacter fetus of reptile origin as a human pathogen. J. Clin. Microbiol. 42, 4405–4407 (2004).

  156. 156.

    , , & Abortion and perinatal sepsis associated with Campylobacter infection. Rev. Infect. Dis. 8, 397–402 (1986).

  157. 157.

    , , & Meningitis in adults due to Campylobacter fetus subspecies fetus. Clin. Infect. Dis. 27, 906–907 (1998).

  158. 158.

    & Human Vibrio fetus infection. Report of two dissimilar cases. Am. J. Dis. Child. 112, 459–462 (1966).

  159. 159.

    , & Septic abortion associated with Campylobacter fetus subspecies fetus infection: case report and review of the literature. Infection 21, 331–333 (1993).

  160. 160.

    et al. Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis. Anaerobe 11, 97–98 (2005).

  161. 161.

    in Campylobacters, Helicobacters and related organisms (eds Newell, D. G. et al.) 475–479 (Plenum Press, New York, 1996).

  162. 162.

    , , , & Campylobacter lanienae sp. nov., a new species isolated from workers in an abattoir. Int. J. Syst. Evol. Microbiol. 50, 865–872 (2000).

  163. 163.

    , & Campylobacter lari associated with permanent pacemaker infection and bacteremia. Clin. Infect. Dis. 27, 220–221 (1998).

  164. 164.

    , , & Isolation of Campylobacter sputorum biovar sputorum from an axillary abscess. J. Infect. 24, 175–179 (1992).

  165. 165.

    , & Bacteremia due to Campylobacter sputorum Biovar sputorum. Clin. Infect. Dis. 27, 1544–1545 (1998).

  166. 166.

    , , , & Emended description of Campylobacter sputorum and revision of its infrasubspecific (biovar) divisions, including C. sputorum biovar paraureolyticus, a urease-producing variant from cattle and humans. Int. J. Syst. Bacteriol. 48, 195–206 (1998).

  167. 167.

    et al. Human disease associated with “Campylobacter upsaliensis” (catalase-negative or weakly positive Campylobacter species) in the United States. J. Clin. Microbiol. 27, 66–73 (1989).

  168. 168.

    & Campylobacter upsaliensis isolated from a breast abscess. J. Clin. Microbiol. 30, 1354–1356 (1992).

  169. 169.

    , , & The internal transcribed spacer region, a new tool for use in species differentiation and delineation of systematic relationships within the Campylobacter genus. Appl. Environ. Microbiol. 76, 3071–3081 (2010).

  170. 170.

    , & Isolation of Bacteroides ureolyticus (B. corrodens) from clinical infections. J. Clin. Pathol. 35, 309–312 (1982).

  171. 171.

    , , & Campylobacter canadensis sp. nov., from captive whooping cranes in Canada. Int. J. Syst. Evol. Microbiol. 57, 2636–2644 (2007).

  172. 172.

    , , , & Enumeration and identification of Campylobacter species in the liver and bile of slaughtered cattle. Int. J. Food Microbiol. 118, 259–263 (2007).

  173. 173.

    et al. Temporal prevalence of antimicrobial resistance in Campylobacter spp. from beef cattle in Alberta feedlots. Appl. Environ. Microbiol. 72, 4088–4095 (2006).

  174. 174.

    , & Detection and genotypic differentiation of Campylobacter jejuni and Campylobacter coli strains from laying hens by multiplex PCR and fla-typing. Res. Vet. Sci. .

  175. 175.

    et al. Easy-to-use rapid test for direct detection of Campylobacter spp. in chicken feces. J. Food Prot. 72, 2483–2488 (2009).

  176. 176.

    & Prevalence and antibiotic susceptibility of thermophilic Campylobacter isolates from free range domestic duck (Cairina moschata) in Morogoro municipality, Tanzania. Trop. Anim. Health Prod. 42, 165–172 (2010).

  177. 177.

    et al. Campylobacter enteritis associated with consumption of raw goat's milk. Lancet 1, 1037–1038 (1985).

  178. 178.

    et al. Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaques. Infect. Immun. 71, 4079–4086 (2003).

  179. 179.

    , , & Isolation of Campylobacter jejuni and Campylobacter coli from the gall bladder samples of sheep and identification by polymerase chain reaction. J. Vet. Med. B Infect. Dis. Vet. Public Health 50, 294–297 (2003).

  180. 180.

    & Emerging thermotolerant Campylobacter species in healthy ruminants and swine. Foodborne Pathog. Dis. 8, 807–813 (2011).

  181. 181.

    et al. Immunohistochemical identification of Campylobacter fetus in natural cases of bovine and ovine abortions. J. Vet. Med. B Infect. Dis. Vet. Public Health 52, 138–141 (2005).

  182. 182.

    , , & Identification of Campylobacter fetus subspecies by phenotypic differentiation and PCR. J. Clin. Microbiol. 44, 2019–2024 (2006).

  183. 183.

    et al. A multiplex polymerase chain reaction to detect and differentiate Campylobacter fetus subspecies fetus and Campylobacter fetus -species venerealis: use on UK isolates of, C. fetus and other Campylobacter spp. J. Appl. Microbiol. 99, 758–766 (2005).

  184. 184.

    & Isolation of Campylobacter fetus from a pet turtle. J. Clin. Microbiol. 21, 260–261 (1985).

  185. 185.

    , , , & Campylobacter hyointestinalis” sp. nov.: a new species of Campylobacter found in the intestines of pigs and other animals. J. Clin. Microbiol. 21, 715–720 (1985).

  186. 186.

    , & Campylobacter hyointestinalis-associated enteritis in Moluccan rusa deer (Cervus timorensis subsp. Moluccensis). J. Comp. Pathol. 97, 687–694 (1987).

  187. 187.

    et al. Campylobacter hyointestinalis subsp. hyointestinalis, a common Campylobacter species in reindeer. J. Appl. Microbiol. 92, 717–723 (2002).

  188. 188.

    et al. Campylobacter insulaenigrae isolates from northern elephant seals (Mirounga angustirostris) in California. Appl. Environ. Microbiol. 73, 1729–1735 (2007).

  189. 189.

    et al. Campylobacter insulaenigrae sp. nov., isolated from marine mammals. Int. J. Syst. Evol. Microbiol. 54, 2369–2373 (2004).

  190. 190.

    , , , & Campylobacter insulaenigrae: first isolation report from South American sea lion (Otaria flavescens [Shaw, 1800]). Braz. J. Microbiol. 42, 261–265 (2011).

  191. 191.

    Salmonella and Campylobacter spp. in Northern Elephant Seals, California. Emerg. Infect. Dis. 11, 1967–1969 (2005).

  192. 192.

    , , & Description of Campylobacter laridis, a new species comprising the nalidixic acid resistant thermophilic Campylobacter (NARTC) group. Curr. Microbiol. 8, 231–238 (1983).

  193. 193.

    et al. Wild raptors as carriers of antimicrobial-resistant Salmonella and Campylobacter strains. Vet. Rec. 168, 565 (2011).

  194. 194.

    et al. Genetic heterogeneity of the cytolethal distending toxin B (cdtB) gene locus among isolates of Campylobacter lari. Br. J. Biomed. Sci. 63, 179–181 (2006).

  195. 195.

    et al. Campylobacter upsaliensis” isolated from cats as identified by DNA relatedness and biochemical features. J. Clin. Microbiol. 27, 2376–2378 (1989).

  196. 196.

    et al. Isolation of Bacteroides ureolyticus from the equine endometrium. J. Vet. Diagn. Invest. 6, 127–130 (1994).

  197. 197.

    , , & Unusual infectious complication in a pregnant woman. Spontaneous abortion caused by Campylobacter coli. Lakartidningen 90, 4356–4357 (1993).

  198. 198.

    , , & Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clin. Infect. Dis. 45, 29–38 (2007).

  199. 199.

    , & Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA. Arthritis Res. Ther. 5, R1–R8 (2003).

  200. 200.

    , & Campylobacter fetus endocarditis: two case reports and review. Clin. Infect. Dis. 18, 443–446 (1994).

  201. 201.

    & Septic abortion with intact fetal membranes caused by Campylobacter fetus subsp. fetus. J. Clin. Microbiol. 32, 1608–1609 (1994).

  202. 202.

    , & Pyogenic vertebral osteomyelitis caused by Campylobacter fetus subspecies fetus. A case report. Spine (Phila Pa 1976) 24, 582–584 (1999).

  203. 203.

    et al. Bacteroides gracilis, an important anaerobic bacterial pathogen. J. Clin. Microbiol. 22, 799–802 (1985).

  204. 204.

    et al. Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology 137, 495–501 (2009).

  205. 205.

    , & Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin. Gastroenterol. Hepatol. 5, 465–469 (2007).

  206. 206.

    , , & Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis. Can. J. Gastroenterol. 21, 453–455 (2007).

  207. 207.

    , & Quantifying the association between Campylobacter infection and Guillain-Barre syndrome: a systematic review. J. Health Popul. Nutr. 28, 545–552 (2010).

  208. 208.

    , , , & Short- and long-term effects of bacterial gastrointestinal infections. Emerg. Infect. Dis. 14, 143–148 (2008).

  209. 209.

    , , & The Miller Fischer syndrome following Campylobacter enteritis: a report of two cases. J. Neurol. Neurosurg. Psychiatry 50, 1557–1558 (1987).

  210. 210.

    et al. Campylobacter jejuni-associated hemolytic-uremic syndrome in a mother and daughter. Pediatrics 71, 253–256 (1983).

  211. 211.

    et al. Three cases of severe invasive infections caused by Campylobacter rectus and first report of fatal C. rectus infection. J. Clin. Microbiol. 49, 1687–1691 (2011).

  212. 212.

    , , , & First attempt to produce experimental Campylobacter concisus infection in mice. World J. Gastroenterol. 14, 6954–6959 (2008).

  213. 213.

    et al. Increased TLR4 expression in murine placentas after oral infection with periodontal pathogens. Placenta 30, 156–162 (2009).

  214. 214.

    , , & Chronic atrophic gastritis in SCID mice experimentally infected with Campylobacter fetus. Infect. Immun. 68, 2110–2118 (2000).

Download references

Acknowledgements

I am grateful to my colleagues who provided helpful suggestions for this Review article: R. O. Gilbert (Cornell University, USA), H. M. Mitchell and N. O. Kaakoush (The University of New South Wales, Australia), and P. Tourlomousis and D. Raghunathan (University of Cambridge, UK). I would also like to thank the Cambridge Commonwealth Trust and the Cambridge Australia Trust for their kind support. I apologize to my colleagues whose work was not cited in the Review owing to space limitations.

Author information

Affiliations

  1. Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK.  smm77@cam.ac.uk

    • Si Ming Man

Authors

  1. Search for Si Ming Man in:

Competing interests

The author declares no competing financial interests.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrgastro.2011.191

Further reading